Cure My Disease

Don't miss your cure!

 Log in / Sign up

Simple drugs may make a tricky gut procedure smoother

NCT ID NCT07461389

Symptom relief Sponsor: CMH Lahore Medical College and Institute of Dentistry Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether giving simethicone (a defoaming agent) and dicyclomine (which reduces gut spasms) before or during an ERCP procedure improves how well doctors can see and work. 90 adults were split into three groups: one got no extra medication, one got simethicone before the procedure, and one got it during. The goal was to see if these drugs led to clearer views and less gut movement, making the procedure quicker and easier for the doctor.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

90 people

The number who actually took part.

Started

Oct 2025

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. All patients presenting for ERCP older than 18years of age. 2. Patients willing to participate in the study, meeting criteria No. 1 Exclusion Criteria: 1. Cases that are abandoned due to inability to access the ampulla 2. Patients with grossly altered anatomy resulting in extended procedure time

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Motility disorder of intestine are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

intestinal motility disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Motility disorder of intestine Mucosal clarity

Contacts and locations

Locations

  • CMH Lahore Medical College

    Lahore, Punjab Province, Pakistan